PHAXIAM Therapeutics
Innovative red blood cell therapeutics
- B2B
About PHAXIAM Therapeutics
Development of red blood cell-based therapies targeting cancer cell metabolism by encapsulating drugs to treat severe cancers and orphan diseases.
Key facts
- Industry
- Biotechnology
- Company size
- 11–50 employees
- Headquarters
- Lyon, Rhône-Alpes, France
- Founded
- 2004
- Revenue
- $7.5M – $59.1MTamtam estimate
- Website
- phaxiam.com
- linkedin.com/company/phaxiam
PHAXIAM Therapeutics at a glance
PHAXIAM Therapeutics is a B2B company in the Biotechnology industry, headquartered in Lyon, Rhône-Alpes, France.
PHAXIAM Therapeutics was founded in 2004.
PHAXIAM Therapeutics has 11–50 employees.
PHAXIAM Therapeutics's revenue is $7.5M – $59.1M (Tamtam estimate).
Selling to companies like PHAXIAM Therapeutics?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies